鄭逸如、吳治勳、黃芸新（2008）．慢性病患者之死亡威脅、慢性病威脅與憂鬱：
個人建構理論的觀點．
中華心理衛生學刊，
2（1），51-73。盧瑞芬、曾旭民、蔡益堅（2003）．「國人生活品質評量（I）：SF-36 台灣版的發 展及心理計量特質分析」．
台灣公共衛生雜誌，
22（6），501-511。鄭逸如、吳治勳、黃芸新. (2008). 慢性病患者之死亡威脅、慢性病威脅與憂鬱：個 人建構理論的觀點.
中華心理衛生學刊
21（1), 23.賴貞嬌、陳漢瑛（2007）．臺北市國民小學教師健康促進生活型態與幸福感之關係研 究．
學校衛生，
51，37-52。藍毓莉、徐祥明、劉文健、曾洙荔、平烈勇（2006）．長期住院慢性精神病患之體重 過重問題．
臺灣精神醫學，
20（4），305-315。魏米秀、呂昌明（2005）「健康促進生活型態」中文簡式量表之發展研究，
衛生教育
學報，
24，25-46。蘇妙秋、許禎娟、林彥如、曾雯琦（2007）．照護一位服用抗精神病藥物致體重過重 患者之護理經驗．
護理雜誌，
54（1），90-96。台灣健康減重推廣協會．（2009）．你超重了嗎？．2010 年 5 月 10 日取自 http://www.bmi-22.org.tw/papers/papers_detail.asp?id=63
行政院主計處．（2009）．國民所得統計及國內經濟情勢展望．2010 年 5 月 10 日取 自http://www.dgbas.gov.tw/public/data/dgbas03/bs4/ninews/9905/newtotal9905.pdf 行政院衛生署（2007，12 月 15 日）．
代謝症候群
-成人（
20歲以上）代謝症候群之
判定標準（
2006台灣）
．2008 年 10 月 5 日取自http://www.bhp.doh.gov.tw/BHPNET/Portal/Them_Show.aspx?Subject=200712250 023&Class=2&No=200712250123
財團法人台灣癌症基金會（2009）BMI 值與癌症風險．2009 年 10 月 5 日取自
http://www.canceraway.org.tw/PreventCancer_Show.asp?AppCode=SITEPAGES&I
D=371
英文部分
Pende, N. J., (1987). Health promotion in nursing practice. (2nd ed.). Norwalk, CT:
Appleton & Lange.
Pende, N. J., (2006). Health promotion in nursing practice. (5th ed.). Norwalk, CT:
Appleton & Lange.
Travis. J. W. (1977). Wellness workbook for health professionals. Mill Valley, CA:
Weliness Resource Center.
Wallack, L.,(2000). Strategies for reducing youth violence: Media, community, and policy.
In M. S. Jamner & D. Stokols(Eds.), Promoting human wellness: New frontiers for research, practice and policy. (pp.507-540). Berkely: University of California Press.
Ardell, D. B. (1979). The nature and implications of high level weilness. or why “normal health” is a rather sorry state of existence. Health Values, 3(1), 17-24.
Archie, S. M., Goldberg, J. O., Akhtar-Danesh, N., Landeen, J., McColl, L., & McNiven, J. (2007). Psychotic disorders, eating habits, and physical activity: who is ready for lifestyle changes? Psychiatr Serv, 58(2), 233-239.
Badia, X., Podzamczer, D, Moral, I., Roset, M., Amaiz, J. A., Lonca, M., Casiro, A., Roson, B., Gatell, J. M., & BestQol Study Group. (2004). Health-related quality of life in HIV patients switching to twice-daily indinavir/ritonavir regimen or
continuing with three-times-daiIy indinavir-based therapy. Antiviral Therapy,9(6), 979-985.
Balgrosky, J. A., Strum, D. W., & Bradley, E. (1982). Evaluation ensures performance.
Hospitals, 56, p. 82.
Bell, R. J. M., Farmer, S. M., Ries, R. M., & Srebnik, D. P. （2009）. Metabolic Risk Factors Among Medicaid Outpatients With Schizophrenia Receiving
Second-Generation Antipsychotics. Psychiatric Services, 60（12）, 1686.
Brown, P. A., & Piper, S. M. （1997）. Nursing and the health of the nation: schism or symbiosis? Journal of Advanced Nursing, 25（2）, 297-301。
Brown, S., Birtwistle, J., Roe, L., & Thompson, C. （1999）. The unhealthy lifestyle of people with schizophrenia. Psychol Med, 29（3）, 697-701.
Brunero, S., & Lamont, S. （2010）. Health behaviour beliefs and physical health risk factors for cardiovascular disease in an outpatient sample of consumers with a severe mental illness: A cross-sectional survey. International Journal of Nursing Studies, 47（6）, 753-760.
Chen, C. H., Chiu, C. C., Huang, M. C., Wu, T. H., Liu, H. C., & Lu, M. L. （2008）.
Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine. Prog Neuropsychopharmacol Biol Psychiatry, 32（4）, 925-931 Chu, N. F. （2005）. Prevalence of obesity in Taiwan. Obes Rev, 6（4）, 271-274.
Cockerham WC. Rutten A, Abel T. （1997）. Conceptualizing contemporary health lifestyles: moving beyond Weber. Sociol Q, 38, 32l-342.
Cockerham WC. （2000） The sociology of health behavior and health lifestyles. In: Bird C, Conrad P, Fremont AM eds. Handbook of Medical Sociology. 5thed. New Jersey: Prentice-Hall,;l59-172.
Cohen, D. （2004）. Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature. Pharmacopsychiatry, 37（1）, 1-11.
Cordes, J., Sinha-Roder, A., Kahl, K. G., Malevani, J., Thuenker, J., Lange-Asschenfeldt, C., et al. （2008）. [Therapeutic options for weight management in schizophrenic patients treated with atypical antipsychotics]. Fortschr Neurol Psychiatr, 76（12）, 703-714.
Correll, C. U. （2008）. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. Journal of Clinical Psychiatry, 69 Suppl 4, 26-36.
Correll, C. U., Frederickson, A. M., Kane, J. M., & Manu, P. （2007）. Does antipsychotic polypharmacy increase the risk for metabolic syndrome? Schizophr Research, 89
（1-3）, 91-100.
Correll, C. U., Kane, J. M., & Manu, P. （2008）. Identification of high-risk coronary heart disease patients receiving atypical antipsychotics: single low-density
lipoprotein cholesterol threshold or complex national standard? Journal of Clinical Psychiatry, 69（4）, 578-583.
Correll, Christoph U.; Frederickson, Anne M.; Kane, John M.; Manu, Peter. ,（2008）.
Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics. Bipolar Disorders, 10（7）,788-797.
de Freitas, M. C., & Mendes, M. M. (2007). Chronic health conditions in adults: concept analysis. Rev Lat Am Enfermagem, 15(4), 590-597.
de Leon, J., & Diaz, F. J. （2005）. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. [doi: DOI:
10.1016/j.schres.2005.02.010]. Schizophrenia Research, 76（2-3）, 135-157.
Fowler, S. B. ((1996). ,1997). Health promotion in chronically ill older adults. Journal of Neuroscience Nursing, 28, 29((5) ,(1)), 39-43.
Freitas , M.C., & Mendes, M. M. R.（2007）. Chronic health conditions in adults: concept analysis. Julho-agosto, 15（4）, 590-597.
Gary, R. (2006). Schizophrenia, Antipsychotics, and the Metabolic Syndrome: Is There a Silver Lining? The American Journal of Psychiatry, 163(7), 1132.
Gillis, A. J. (1993). Determinants of a health-promoting lifestyle: an integrative review. J Adv Nurs, 18(3), 345-353.
Hsiao, C.-C., Ree, S.-C., Chiang, Y.-L., Yeh, S.-S., & Chen, C.-K. （2004）. Obesity in schizophrenic outpatients receiving antipsychotics in Taiwan. Psychiatry And Clinical Neurosciences, 58（4）, 403-409.
Khanlou, N. (2003). Mental health promotion education in multicultural settings. Nurse Educ Today, 23(2), 96-103.
Kiraly, B., Gunning, K., & Leiser, J.（2008）. Primary care issues in patients with mental illness. American Family Physician, 78（3）, 355-362.
Koponen, H., Alaraisanen, A., Saari, K., Pelkonen, O., Huikuri, H., Raatikainen, M. J. P., et al. （Writer）. （2008）. Schizophrenia and sudden cardiac death? A review [Article], Nordic Journal of Psychiatry.
Kumanyika SK.(2001) Minisymposium on obesity: overview and some strategic considerations. Ann Rev Public Health, 22,293–308
Lalonde,M.(1974). A New Perspective on the Health of Canadians: a Working Document.Retrieved from Government of Canada, web
site:heep//www.hc-sc.ca/hppb/healthpromotiondevelopment/pdf/perspective.pdf Lamberti, J. S., Olson, D., Crilly, J. F., Olivares, T., Williams, G. C., Tu, X., et al. （2006）.
Prevalence of the metabolic syndrome among patients receiving clozapine. Am Journal of Psychiatry, 163（7）, 1273-1276.
Lawrence, W. (2000). Good intentions gone wrong? British Medical Journal, 320(7235),
656.
Luc F. Van Gaal.（2006）. Long-term health considerations in schizophrenia: metabolic effects and the role of abdominal adiposity.，European Neuropsychopharmacology, 16, 142-148.
Ma GX（1999） The Culture of Health:Asian Communities in the United State.
Connecticut, USA, Bergin & Garvey.
M, D. E. H., Schreurs, V., Vancampfort, D., & R, V. A. N. W. （2009）. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry, 8（1）, 15-22.
Mh, H. （1991）. Perspectives on health. Nursing science quarterly, 4（1） , p. 33-40.
Michi, K.-i., Yamashita, Y., Imai, S., Suzuki, N., & Yoshida, H. (1993). Role of visual feedback treatment for defective /s/ sounds in patients with cleft palate. Journal of Speech and Hearing Research, 36(2), 277.
Nazilla, K.,(2003). Mental health promotion education in multicultural. Nurse ducation Today settings, 23 , 96–103
Pack, S. （2009）. Poor physical health and mortality in patients with schizophrenia.
Nursing Standard, 23（21）, 41.
Pender, N. J., Murdaugh, C. L., & Parsons, M. A. （2006）. Health Promotion in Nursing Practice （5th ed., pp15-73）. New Jersey: Pearson.
Ryan, M. C., & Thakore, J. H. (2002). Physical consequences of schizophrenia and its
treatment: the metabolic syndrome. Life Sci, 71(3), 239-257.
Rothbard, A. S., Blank, M. P., Staab, J. M. M., TenHave, T. P. M. P. H., Young, D. M. D.
P., Berry, S. A., et al. （2009）. Previously Undetected Metabolic Syndromes and Infectious Diseases Among Psychiatric Inpatients. Psychiatric Services, 60（4）, 534.
Rothbard, A. S., Blank, M. P., Staab, J. M. M., TenHave, T. P. M. P. H., Young, D. M. D.
P., Berry, S. A., et al. （2009）. Previously Undetected Metabolic Syndromes and Infectious Diseases Among Psychiatric Inpatients. Psychiatric Services, 60（4）, 534.
Saarni, S., Fogelholm, M., Heliövaara, M., Perälä, J., Suvisaari, J., & Lönnqvist, J.
（2009）. Body composition in psychotic disorders: a general population survey.
Psychological Medicine, 39（5）, 801.
Simpson, G. M., Glick, I. D., Weiden, P. J., Romano, S. J., & Siu, C. O. （2004）.
Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with
schizophrenia or schizoaffective disorder. Am Journal of Psychiatry, 161（10）, 1837-1847.
Sola, C. L., & Bostwiclk, J. M. (2005). Implantable cardioverter-defibril1ators, induced anxiety, and quality of life. Mayo Clinic Proceeding. 80(2),232-237.
Susan, D.（1998）.Health-within-illness: concept development through research and practice. Journal of Advanced Nursing, 28（2）, 305-310.
Susan, J, S.(1989) Health: a concept analysis.Int. J. Nurs. Stud.,26(2), 155-161.
Swartz, M. S., Stroup, T. S., McEvoy, J. P., Davis, S. M., Rosenheck, R. A., Keefe, R. S., et al. （2008）. What CATIE found: results from the schizophrenia trial. Psychiatr Serv, 59（5）, 500-506.
Tadger, S., & Melamed, Y. (2008). Weight gain due to long term antipsychotic treatment of persistent mental disorders. Psychiatr Danub, 20(1), 37-41.
Turner, J.(1986). World Health Organization-Charter for health promotion. Lanced, 2,1407.
Thakore, J. H. (2004). Metabolic disturbance in first-episode schizophrenia. Br J Psychiatry Suppl, 47, S76-79.
Tripp-Reimer, T. （1984）. Research in cultural diversity. Western journal of nursing research. 6（1）. 130-132.
Tschoner, A., Engl, J., Rettenbacher, M., Edlinger, M., Kaser, S., Tatarczyk, T., et al.
（2009）. Effects of six second generation antipsychotics on body weight and metabolism - risk assessment and results from a prospective study.
Pharmacopsychiatry, 42（1）, 29-34.
Tunner, J. （1986）. World Health Organization-Charter for health promotion. Lancet, 2,
4107.
Van Gaal, L. F. （2006）. Long-term health considerations in schizophrenia: metabolic effects and the role of abdominal adiposity. European Neuropsychopharmacol, 16 Suppl 3, S142-148.
Van Winkel, R., De Hert, M., Wampers, M., Van Eyck, D., Hanssens, L., Scheen, A., et al.
（2008）. Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder. Journal of Clinical Psychiatry, 69（3）, 472-479.
von Hausswolff-Juhlin, Y., Bjartveit, M., Lindstrom, E., & Jones, P. （2009）.
Schizophrenia and physical health problems. Acta Psychiatr Scand Suppl（438）, 15-21.
Walker, S. N., Sechrist, K. R., & Pender, N. J. (1987). The health-promoting lifestyle profile: Development and psychometric characteristics. Nursing Research, 36(2).
76—81
Weiden, P. J., Cutler, A. J., Polymeropoulos, M. H., & Wolfgang, C. D. （2008）. Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.
Journal of Clinical Psychopharmacol, 28（2 Suppl 1）, S12-19.
Wong TKS & Pang SMC(2000) Holism and caring: nursing in Chinese health care
culture. Holistic Nursing Practice 15, 12-21.
World Health Organization. (1984). Report of the working group on concepts and principles of health promotion. Copenhagen, Denmark: WHO.
Wu, M. K., Wang, C. K., Bai, Y. M., Huang, C. Y., & Lee, S. D. （2007）. Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program. Psychiatry Serv, 58（4）, 544-550.
Yevtushenko, O. O., Cooper, S. J., O'Neill, R., Doherty, J. K., Woodside, J. V., &
Reynolds, G. P. (2008). Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia. Br J Psychiatry, 192(6), 424-428.
附錄一人體試驗委員會通過同意函
附錄二 研究問卷---個人基本資料
編號：
填表日期： 年 月 日 1. 性別：□1 男 □女
2. 出生： 年 月 日
3. 教育程度：□不識字 □國小或未上國小但是識字 □國中 □高中 □專科
□大學 □研究所
4. 婚姻狀況：□未婚 □已婚 □同居 □分居 □離婚 □喪偶 5. 宗教信仰：□無 □有
6. 請問您知道自己的病名嗎？
□精神分裂症 □躁鬱症 □其他： □無
7. 請問您除了精神科疾病外，您有其他醫師診斷之疾病嗎？
□無 □高血壓 □糖尿病 □其他：
8. 請問您過去 6 個月，平均個人月收入為：□4999 元以下 □5000~9999 元
□10000~19999 元 □20000~29999 元 □30000~39999 元 □40000 元以上 9. 您覺得您的收入夠支付您生活的需要嗎？□夠 □不夠
10. 請問您這星期平均每天白天約睡幾小時？
□ 0~2 小時 □2~4 小時 □4~6 小時 □6~8 小時 □8 小時以上 11. 請問您這星期平均每天晚上約睡幾小時？（扣除白天睡眠）
□0~2 小時 □2~4 小時 □4~6 小時 □6~8 小時 □8 小時以上
總是
附錄四
SF-36 台灣版健康量表問卷